Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Herrstedt

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 27, 2014
Early recognition of malnutrition and cachexia in the cancer patient: a position paper of a European School of Oncology Task ForceM Aapro, J Arends, F Bozzetti, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 2, 2006
Combined data from two phase III trials of the NK1 antagonist aprepitant plus a 5HT 3 antagonist and a corticosteroid for prevention of chemotherapy-induced nausea and vomiting: effect of gender on treatment responseP J Hesketh, S M Grunberg, J Herrstedt, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 30, 2018
Amisulpride prevents nausea and vomiting associated with highly emetogenic chemotherapy: a randomised, double-blind, placebo-controlled, dose-ranging trialJ Herrstedt, Y Summers, K Jordan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2017
European Society for Medical Oncology (ESMO) position paper on supportive and palliative careK Jordan, M Aapro, S Kaasa, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 1, 1997
Clinical and methodological issues in antiemetic therapy: a worldwide survey of experts' opinions. Multinational Association of Supportive Care in CancerE Ballatori, F Roila, V De Angelis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2018
Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice GuidelinesM Aapro, Y Beguin, C Bokemeyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 23, 2018
Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice GuidelinesM Aapro, Y Beguin, C Bokemeyer, et al.
Acta Oncologica (Stockholm, Sweden)|March 1, 2021
Severity and 1-month outcome of SARS-CoV-2 infection in patients with solid cancers: a Danish nationwide cohort studyS Ehmsen, L H Jakobsen, M E Lendorf, et al.
Gynecologic Oncology|November 24, 2018
Early tumor regrowth is a contributor to impaired survival in patients with completely resected advanced ovarian cancer. An exploratory analysis of the Intergroup trial AGO-OVAR 12F Heitz, P Harter, E Åvall-Lundqvist, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 25, 2016
2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patientsF Roila, A Molassiotis, J Herrstedt, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 27, 2014
Early recognition of malnutrition and cachexia in the cancer patient: a position paper of a European School of Oncology Task ForceM Aapro, J Arends, F Bozzetti, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 2, 2006
Combined data from two phase III trials of the NK1 antagonist aprepitant plus a 5HT 3 antagonist and a corticosteroid for prevention of chemotherapy-induced nausea and vomiting: effect of gender on treatment responseP J Hesketh, S M Grunberg, J Herrstedt, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 30, 2018
Amisulpride prevents nausea and vomiting associated with highly emetogenic chemotherapy: a randomised, double-blind, placebo-controlled, dose-ranging trialJ Herrstedt, Y Summers, K Jordan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2017
European Society for Medical Oncology (ESMO) position paper on supportive and palliative careK Jordan, M Aapro, S Kaasa, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 1, 1997
Clinical and methodological issues in antiemetic therapy: a worldwide survey of experts' opinions. Multinational Association of Supportive Care in CancerE Ballatori, F Roila, V De Angelis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2018
Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice GuidelinesM Aapro, Y Beguin, C Bokemeyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 23, 2018
Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice GuidelinesM Aapro, Y Beguin, C Bokemeyer, et al.
Acta Oncologica (Stockholm, Sweden)|March 1, 2021
Severity and 1-month outcome of SARS-CoV-2 infection in patients with solid cancers: a Danish nationwide cohort studyS Ehmsen, L H Jakobsen, M E Lendorf, et al.
Gynecologic Oncology|November 24, 2018
Early tumor regrowth is a contributor to impaired survival in patients with completely resected advanced ovarian cancer. An exploratory analysis of the Intergroup trial AGO-OVAR 12F Heitz, P Harter, E Åvall-Lundqvist, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 25, 2016
2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patientsF Roila, A Molassiotis, J Herrstedt, et al.
Pageof 7